Clinical trials
Terminated Obesity trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
23 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 2 |
| 2005 | 2 |
| 2006 | 4 |
| 2007 | 2 |
| 2010 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 23 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pfizer | 3 |
| Sanofi | 3 |
| Hamilton Health Sciences Corporation | 2 |
| University of British Columbia | 2 |
| Alnylam Pharmaceuticals | 1 |
| Centre for Addiction and Mental Health | 1 |
| Health Parametrics Inc. | 1 |
| InovoBiologic Inc. | 1 |
| Laval University | 1 |
| McMaster University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Obesity | 23 |
| Diabetes Mellitus, Type 2 | 5 |
| Cardiovascular Diseases | 2 |
| Diabetes Mellitus | 2 |
| Heart Failure | 2 |
| Hypertension | 2 |
| Metabolic Syndrome | 2 |
| Obesity, Morbid | 2 |
| Overweight | 2 |
| Weight Gain | 2 |
Trials
Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.